These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 14513687

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Overview of monoclonal antibodies in cancer therapy: present and promise.
    Stern M, Herrmann R.
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
    Buchsbaum DJ, Khazaeli MB, Axworthy DB, Schultz J, Chaudhuri TR, Zinn KR, Carpenter M, LoBuglio AF.
    Clin Cancer Res; 2005 Nov 15; 11(22):8180-5. PubMed ID: 16299250
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Actinium-225 conjugates of MAb CC49 and humanized delta CH2CC49.
    Kennel SJ, Brechbiel MW, Milenic DE, Schlom J, Mirzadeh S.
    Cancer Biother Radiopharm; 2002 Apr 15; 17(2):219-31. PubMed ID: 12030116
    [Abstract] [Full Text] [Related]

  • 7. Screening at the National Cancer Institute.
    Goldin A, Venditti JM, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar 15; (45):37-48. PubMed ID: 337155
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S, Wittes R.
    Cancer Treat Rep; 1984 Jan 15; 68(1):77-85. PubMed ID: 6362870
    [No Abstract] [Full Text] [Related]

  • 10. Immunotoxin therapy of malignancy.
    Grossbard ML, Nadler LM.
    Important Adv Oncol; 1992 Jan 15; ():111-35. PubMed ID: 1582669
    [No Abstract] [Full Text] [Related]

  • 11. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD, Greenwald P.
    Semin Oncol; 1983 Sep 15; 10(3):360-4. PubMed ID: 6665563
    [No Abstract] [Full Text] [Related]

  • 12. Antibody-guided radiation therapy of cancer.
    Koppe MJ, Postema EJ, Aarts F, Oyen WJ, Bleichrodt RP, Boerman OC.
    Cancer Metastasis Rev; 2005 Dec 15; 24(4):539-67. PubMed ID: 16408161
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody treatment of solid tumors: a coming of age.
    Murray JL.
    Semin Oncol; 2000 Dec 15; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030
    [Abstract] [Full Text] [Related]

  • 14. Antibody-based targeted radiation to pediatric tumors.
    Modak S, Cheung NK.
    J Nucl Med; 2005 Jan 15; 46 Suppl 1():157S-63S. PubMed ID: 15653664
    [Abstract] [Full Text] [Related]

  • 15. In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants.
    De Pascalis R, Gonzales NR, Padlan EA, Schuck P, Batra SK, Schlom J, Kashmiri SV.
    Clin Cancer Res; 2003 Nov 15; 9(15):5521-31. PubMed ID: 14654532
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FR-901228 Fujisawa/National Cancer Institute.
    Vigushin DM.
    Curr Opin Investig Drugs; 2002 Sep 15; 3(9):1396-402. PubMed ID: 12498018
    [Abstract] [Full Text] [Related]

  • 19. Serotherapy of cancer.
    Harris DT, Mastrangelo MJ.
    Semin Oncol; 1989 Jun 15; 16(3):180-98. PubMed ID: 2658082
    [No Abstract] [Full Text] [Related]

  • 20. Technological advances in radioimmunotherapy.
    Dearling JL, Pedley RB.
    Clin Oncol (R Coll Radiol); 2007 Aug 15; 19(6):457-69. PubMed ID: 17537620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.